共 50 条
What do we know about memory B cells in primary Sjogren's syndrome?
被引:25
作者:
Hansen, Arne
[1
,2
]
Daridon, Capucine
[3
]
Doerner, Thomas
[3
]
机构:
[1] Akad Lehrkrankenhaus Charite, Pk Klink Weissensee, Dept Med, D-13086 Berlin, Germany
[2] Charite, Outpatients Dept Med, Berlin, Germany
[3] Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany
关键词:
Primary Sjogrens syndrome;
Autoimmunity;
Memory B cells;
Lymphoma;
Rituximab;
DEPRESSED PERCENTAGE;
AUTOIMMUNE-DISEASES;
SALIVARY-GLANDS;
BLOOD;
EXPRESSION;
RITUXIMAB;
CD27;
HETEROGENEITY;
CORRELATE;
LYMPHOMA;
D O I:
10.1016/j.autrev.2010.05.005
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
Abnormalities of memory B cells seem to be closely involved in the pathogenesis of primary Sjogrens Syndrome (pSS) and its malignant complication, B cell lymphoma. Recent studies on B cells in pSS add to our understanding of the distinct memory B cell subsets in pSS. Reduction of peripheral memory CD27(+) B cells, most strikingly of the CD27(+) IgM(+) subset, may indicate a lack of appropriate censoring mechanisms and Incomplete differentiation processes within the ectopic lymphoid tissues in pSS. This ectopically formed lymphoid tissue might protect autoreactive memory B cells from deletion by physiological check-points and, thereby, may contribute to the perpetuation of the disease as well as to an enhanced lymphoma risk. Thus, B cells may be potential targets of direct or indirect treatment in pSS (C) 2010 Elsevier B V All rights reserved
引用
收藏
页码:600 / 603
页数:4
相关论文